bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.880
+0.220 (8.27%)
At close: Oct 14, 2025, 4:00 PM EDT
2.775
-0.105 (-3.65%)
After-hours: Oct 14, 2025, 7:59 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $12.93 million as of October 14, 2025. Its market cap has decreased by -53.48% in one year.
Market Cap
12.93M
Enterprise Value
12.80M
1-Year Change
-53.48%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $12.93M, a decrease of -71.29%. That is a compound annual growth rate of -32.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 12.93M | -8.83% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |